Open access
Aug 2026
A cuproptosis-related lncRNAs-based risk signature for predicting prognosis and immune status in glioma
This cuproptosis-related lncRNA-based signature demonstrates strong prognostic value and may serve as a promising tool for glioma risk stratification and personalized treatment selection.
Xiang-Dong Lu, Si-Quan Zhu, Jun-Zeng Si et al.
· Translational Cancer Researc... · 0 citations